Motley Fool: A Promising Tech Share

Shares in BTG (LSE: BGC) are on the up this morning after the life sciences company made two positive announcements in 24 hours.

Today’s news was the most exciting. TolerRx, a privately owned US biotech, has raised $36m (£19m) from venture capital backers to take a type 1 diabetes drug called TRX4 into late-stage clinical trials….

Continue reading this article at the Motley Fool

Leave a Comment

Your email address will not be published. Required fields are marked *